Arkolith/Insider Trading/ITCI/Form 4

Marcus Joel S

DirectorIntra-Cellular Therapies, Inc. (ITCI) · full profile →Form 4 · filed Apr 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2025Disposed to issuer(D)10K$132.00$1.3M0
Apr 2, 2025Disposed to issuer(D)48K$132.00$6.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2025Disposed to issuer(D)3K——0
Apr 2, 2025Disposed to issuer(D)4K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-049596) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML